BPC-157 for inflammation helps prevent further injury to the intestinal lining and supports the repair of damaged tissue by stabilizing these inflammatory mediators
But several of its well-documented side effects create conditions in the mouth that make dental problems far more likely
While experiences vary depending on medical history, lifestyle, and dosing stage, most patients notice predictable changes in appetite, food intake, and weight over time
To comply with patent laws, THIS MEDICATION WILL ONLY PRESCRIBED TO PATIENTS THAT REQUIRE ADDITIONAL INGREDIENTS COMPOUNDED WITH THE ACTIVE INGREDIENT (for management of nausea, etc) OR REQUIRE DOSING BEYOND WHAT IS COMMERCIALLY AVAILABLE
It cites a BMI of 27 or higher with a weight-related comorbidity, or a BMI of 30 or higher, plus motivation for lifestyle change and the ability to tolerate gastrointestinal side effects such as nausea and vomiting early in treatment
& Fu, J